Quick Answer
Neumora Therapeutics, Inc. reported Long Term Debt of $54.53 million for the year ending 2025.
- This data is from Neumora Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2025 to 2025 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2024: $0.00 | Q2 2025: $19.45 million | Q3 2025: $19.56 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: